
MGB Biopharma Announces Promising Phase IIa Clinical Trial Update for MGB-BP-3
MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance,...
Do you have news for the Scottish Life Sciences Community?
Submit Your Own News